THE FINLEY HOSPITAL
1. Target Overview & Investment Thesis
THE FINLEY HOSPITAL is a 66-bed suburban community hospital in DUBUQUE, IA with $121.7M in net patient revenue and a 0.1% operating margin. The hospital serves a payer mix of 46.7% Medicare, 17.9% Medicaid, and 35.4% commercial.
Thesis: Turnaround. Our ML models identify $9.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.1% to 7.5% (+736bps).
| Net Revenue HCRIS | $121.7M |
| Current EBITDA COMPUTED | $142K |
| Operating Margin COMPUTED | 0.1% |
| Occupancy HCRIS | 61.9% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 33.2% |
| Distress Probability ML | 48.9% |
2. Market Context & Competitive Position
IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of 0.1% places it above the state median. Among 22 size-comparable peers (33-132 beds), the median margin is -17.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (33-132), prioritizing same-state peers. 22 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| THE FINLEY HOSPITAL (Target) | IA | 66 | $121.7M | 0.1% |
| BROADLAWNS MEDICAL CENTER | IA | 113 | $169.5M | -37.0% |
| MERCYONE SIOUXLAND MEDICAL CEN | IA | 125 | $148.2M | -40.8% |
| TRINITY REGIONAL MEDICAL CENTE | IA | 44 | $140.4M | -6.8% |
| JENNIE EDMUNDSON MEMORIAL | IA | 127 | $121.6M | -5.7% |
| MERCYONE CLINTON MEDICAL CENTE | IA | 107 | $116.1M | -19.4% |
| SPENCER MUNICIPAL HOSPITAL | IA | 49 | $108.7M | -10.3% |
| TRINITY BETTENDORF | IA | 81 | $90.6M | -3.7% |
| ST. ANTHONY REGIONAL HOSPITAL | IA | 49 | $84.0M | -21.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $78K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $142K |
| + RCM Uplift | +$9.0M |
| Pro Forma EBITDA | $9.1M |
| Current Margin | 0.1% |
| Pro Forma Margin | 7.5% |
| WC Released (1x) | $4.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $218K | $90.5M | 414.63x | 233.8% |
| Base (11x exit) | 10.0x | 11.0x | $218K | $99.7M | 456.41x | 240.3% |
| Bull Case | 9.0x | 11.0x | $197K | $129.3M | 657.94x | 266.1% |
| Bull (12x exit) | 9.0x | 12.0x | $197K | $141.1M | 718.05x | 272.6% |
| Bear Case | 11.0x | 10.0x | $240K | $45.7M | 190.12x | 185.6% |
| Bear (11x exit) | 11.0x | 11.0x | $240K | $50.3M | 209.46x | 191.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 22 hospitals with 33-132 beds
- Same-state prioritization (n=23)
- Comp margins: P25=-24.5% / P50=-17.4% / P75=-5.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.